http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112402098-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0612 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1601 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00736 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-16 |
| filingDate | 2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112402098-B |
| titleOfInvention | Drug-eluting intraocular lens with slow release function and preparation method thereof |
| abstract | The present invention relates to an intraocular lens and a method of making the same. Aims to provide a drug eluting intraocular lens with slow release function and a preparation method thereof; the intraocular lens can effectively prevent a plurality of common complications after cataract ultrasonic emulsification operation on the premise of not influencing the light transmittance and stability of the intraocular lens, thereby ensuring the recovery of the postoperative visual quality of a patient and avoiding the occurrence of unnecessary serious consequences. The technical scheme is as follows: the drug eluting intraocular lens with the slow release function comprises an optical part of the intraocular lens and a plurality of haptics positioned at the edge of the optical part; the method is characterized in that: the haptics are arranged symmetrically to the center of the optical portion, a drug eluting coating is attached to the surface of each haptic, and the surface area of the drug eluting coating of each haptic is more than 30% of the surface area of the optical portion. |
| priorityDate | 2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.